Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer.
暂无分享,去创建一个
R B Mazess | D L DeMets | D. DeMets | R. Mazess | P. Newcomb | V. Jordan | V. Jordan | R. Love | H. Barden | S. Epstein | P. Carbone | V C Jordan | H S Barden | R R Love | P A Newcomb | S Epstein | P P Carbone
[1] E. Siris,et al. Effects of tamoxifen on spinal bone density in women with breast cancer. , 1989, Journal of the National Cancer Institute.
[2] Jack Cuzick,et al. Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .
[3] V. Jordan,et al. Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture. , 1990, Cancer research.
[4] R. Turner,et al. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. , 1988, Endocrinology.
[5] R. Turner,et al. Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] L. Fisher,et al. Effects of clomiphene and tamoxifen in vivo on the bone-resorbing effects of parathyroid hormone and of high oral doses of calcitriol (1,25(OH)2D3) in rats with intact ovarian function consuming low calcium diet. , 1990, Bone and mineral.
[7] D. DeMets,et al. Effects of tamoxifen therapy on lipid and lipoprotein levels in postmenopausal patients with node-negative breast cancer. , 1990, Journal of the National Cancer Institute.
[8] B. Riggs,et al. Methods and application of bone densitometry in clinical diagnosis. , 1986, Critical reviews in clinical laboratory sciences.
[9] C. Christiansen,et al. The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer , 1984, Cancer.
[10] Norman R. Draper,et al. Applied regression analysis (2. ed.) , 1981, Wiley series in probability and mathematical statistics.
[11] D. DeMets,et al. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women. , 1991, Annals of internal medicine.
[12] C. McDonald,et al. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee. , 1991, BMJ.
[13] R. Turner,et al. Evidence that calcium modulates circulating 25‐hydroxyvitamin D in man , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[14] J. Ware,et al. Random-effects models for longitudinal data. , 1982, Biometrics.
[15] L. Avioli,et al. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. , 1988, The Journal of clinical investigation.
[16] C. Redmond,et al. Prolonging tamoxifen therapy for primary breast cancer. Findings from the National Surgical Adjuvant Breast and Bowel Project clinical trial. , 1987, Annals of internal medicine.
[17] N. Rifai,et al. Biochemical effects of 17β-estradiol on UMR106 cells , 1989 .
[18] W. Mysiw,et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[19] P. Stern,et al. Effects of the antiestrogens tamoxifen and clomiphene on bone resorption in vitro. , 1986, Endocrinology.
[20] F. Bauss,et al. Antiestrogen and antiandrogen administration reduce bone mass in the rat. , 1989, Bone and mineral.
[21] W. Wolberg,et al. Adjuvant trial of 12 cycles of CMFPT followed by observation or continuous tamoxifen versus four cycles of CMFPT in postmenopausal women with breast cancer: an Eastern Cooperative Oncology Group phase III study. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] A. Hart,et al. Bone mineral density after adjuvant chemotherapy for premenopausal breast cancer. , 1990, British Journal of Cancer.
[23] H. Adami,et al. Hip fractures in women with breast cancer. , 1990, American journal of epidemiology.
[24] I. Fentiman,et al. Bone mineral content of women receiving tamoxifen for mastalgia. , 1989, British Journal of Cancer.
[25] S. Epstein,et al. DIFFERENCES IN SERUM BONE GLA PROTEIN WITH AGE AND SEX , 1984, The Lancet.
[26] V. Jordan,et al. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer. , 1987, Cancer research.
[27] H. Sjöberg,et al. Long-term adjuvant tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.